Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Bristol-Myers Squibb Company (BMY)

Healthcare Drug Manufacturers - General
65.30 $
+0.7% vs. previous close
Closing price · As of: 31. Jul 2026

Bristol-Myers Squibb Company (BMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 87,634 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet BMY
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
91,263 95,159 99,031 94,646 93,670 92,603 92,427 94,676 96,889 90,038 86,476 87,634
27,632 31,770 28,669 26,890 28,075 29,780 30,783 33,222 35,630 29,390 27,208 28,579
7,514 11,464 9,330 6,293 7,890 10,346 10,875 12,599 15,726 10,209 9,574 8,722
7,685 12,280 9,670 6,653 8,094 10,859 11,782 13,603 16,502 10,673 10,486 11,067
15,647 15,264 14,060 15,146 14,895 14,424 14,586 15,101 14,616 14,525 12,083 10,553
2,436 2,662 2,985 3,077 3,332 2,557 2,666 2,737 2,758 2,690 2,756 2,737
7,848 6,646 6,750 8,251 8,360 8,428 8,649 8,953 9,125
21,147 21,169 21,738 21,732 21,751 21,719 21,737 21,776 21,745 21,754 21,740 21,740
29,377 27,485 33,167 29,839 27,327 23,643 22,802 21,663 20,465 19,353 18,492 17,387
62,201 65,674 82,483 77,577 76,470 76,215 74,979 77,187 78,289 71,532 66,374 65,315
23,462 22,262 25,822 23,265 22,638 23,774 24,070 27,528 28,136 23,417 19,158 18,659
5,617 3,281 6,359 3,708 1,243 2,227 3,726 4,909 4,723 2,463 2,506 1,027
2,813 3,259 3,539 3,751 3,469 3,602 4,002 5,427 4,288 3,575 4,234 4,158
32,137 36,653 49,487 48,858 48,674 47,603 46,157 44,470 44,469 42,850 42,152 42,093
28,998 29,430 16,490 17,015 17,142 16,335 17,389 17,435 18,552 18,473 20,068 22,319
28,218 28,766 15,640 16,103 16,097 14,912 16,106 16,154 17,093 16,896 18,287 20,316
2,064 2,033 2,023 2,029 2,031 2,037 2,037 2,038 2,038 2,041 2,044 2,048

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?